iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
Insight Molecular Diagnostics appointed Donnie Purto as SVP of Sales to lead commercialization of GraftAssureDx, which is currently under FDA medical device review. Purto brings 20+ years of diagnostics sales leadership, including a decade at Natera spanning transplant and oncology launches.
Key figures
- Drug Name
- GraftAssureDx
- Natera tenure
- decade
- Purto years experience
- 20+
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.